Dr Helen Moor

Post-doctoral researcher

Postgraduate Medical Institute

Faculty:Faculty of Medical Science

Location: Chelmsford

Areas of Expertise: Cell and Molecular Biology

Having a background in Biochemistry, Helen’s knowledge base covers human and viral cell and molecular biology, chemistry, protein chemistry, enzymology and genetics. Her technical expertise includes applications such as cell-based assays, immunohistochemistry, nucleic acid extraction, PCR, sub-cloning and Western blotting.

Untitled Page

Email: helen.moor@anglia.ac.uk

Research interests

Helen has always been fascinated by disease mechanisms and this inspired her doctoral research, which investigated a family of virus-related proteins and their involvement in human cancers. The cancer aspect of her studies fuelled her interest in this field further and has driven more recent research into breast cancer, specifically the quest for markers of chemotherapy response in breast cancer patients. She continues to be interested in many other disease types especially those related to pathogens and she is currently involved in the development of methods of detection of clinically important fungal species such as Aspergillus and Scedosporium.

Areas of research supervision

‘Characterisation of novel protein partners of the CCCTC - binding factor in breast cancer cell lines’

3rd Supervisor of Okezie O. Ofor for Doctor of Philosophy

Qualifications

  • PhD Biochemistry, University of Essex
  • BSc Biochemistry (Hons), University of Essex

Selected recent publications

Moor, H., Ofor, O., Dhillon, H.S., Greenwood, C. and Bustin, S.A. (2013) The Polymerase Chain Reaction. Innovation into Success 33:72-73

Recent presentations and conferences

‘Discovery and characterisation of a retinal protein found in breast cancer’, Helen Moor and Sushma Rai, Khalid Al-Janabi and Christina Greenwood, ‘Research for Change’ Anglia Ruskin University Conference 15th January 2013.

‘Identification and validation of proteins that may be used to predict response to neoadjuvant chemotherapy treatment’, Helen Moor, Khalid Al-Janabi, Sankaran ChandraSekharan, Louise Alldridge, Serhiy Souchelnytskyi and Christina Greenwood, EuPa/BSPR Proteomics Conference Glasgow. 10-12th July 2012.

Identification and validation of tyrosine phosphorylated proteins that may be used to predict response to neoadjuvant chemotherapy treatment’, Helen Moor, Khalid Al-Janabi, Sankaran ChandraSekharan Louise Alldridge, Serhiy Souchelnytskyi and Christina Greenwood, Association of Breast Surgery Conference & AGM, Bournemouth. 21st-22nd May 2012.